BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021; 13(8): 853-867 [PMID: 34552692 DOI: 10.4254/wjh.v13.i8.853]
URL: https://www.wjgnet.com/1948-5182/full/v13/i8/853.htm
Number Citing Articles
1
Yoshihiko Yano, Itsuko Sato, Takamitsu Imanishi, Ryutaro Yoshida, Takanori Matsuura, Yoshihide Ueda, Yuzo Kodama. Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related AntigenDiagnostics 2024; 14(7): 728 doi: 10.3390/diagnostics14070728
2
Jeong Hyun Park, Young-Heun Shin, Won-Bae Chang. An Anatomically Complicated Living Donor Kidney Transplantation from Hepatitis B Surface Antigen-Positive Donor to Negative Recipient With Size DiscrepancyTransplantation Proceedings 2024; 56(3): 494 doi: 10.1016/j.transproceed.2024.01.019
3
Reynold I. Lopez‐Soler, Cara Joyce, Laura Cotiguala, Oswaldo Aguirre, Manpreet Samra, Chrsitine Trotter, Geraldine Zingraf, Jeffrey Sorensen, Rupinder Sodhi, Anne Thorndyke. Utilization of Hepatitis B viremic donors (NAT+) leads to improved kidney transplant access for older adult recipients with little to no wait timeTransplant Infectious Disease 2024;  doi: 10.1111/tid.14295